Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects
- PMID: 1576069
- PMCID: PMC1381333
- DOI: 10.1111/j.1365-2125.1992.tb04062.x
Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects
Abstract
1. We have investigated the capacities of peripheral leukocytes from atopic asthmatic (AA) (n = 7), atopic non-asthmatic (AN) (n = 7), and normal (N) (n = 7) subjects to generate the bronchoconstrictor and proinflammatory mediators leukotrienes (LTs) B4 and C4. 2. Mixed leukocyte preparations containing 61-84% neutrophils, 2.4-15% eosinophils, and 13-29% mononuclear cells were incubated in vitro at 37 degrees C in the presence of calcium ionophore A23187. Synthesis of LTB4 and LTC4 was quantitated by radioimmunoassay. 3. Both in dose-response experiments (0-10 microM A23187 for 5 min), and in time-course investigations (2 microM A23187 for 0-30 min), the mixed leukocytes of the AA and AN subjects generated on average 4- to 5-fold more LTB4 and 3- to 5-fold more LTC4 than the normal leukocytes (P less than 0.01 in all cases; ANOVA). 4. This enhanced LT synthesis by the AN and AA leukocytes was not due to differences in the counts of leukocyte sub-types, or to altered rates of LT catabolism between the subject groups. 5. LTB4 synthesis correlated significantly with LTC4 synthesis in the leukocytes of the AN and AA subjects (r = 0.81, n = 14, P less than 0.01), but not in those of the normal subjects (r = 0.19, n = 7, P greater than 0.05). 6. Our results demonstrate an up-regulation of the leukotriene synthetic pathway in the circulating leukocytes of atopic non-asthmatic and atopic asthmatic subjects, which may have important implications in the pathophysiology of asthma and allergy.
Similar articles
-
The generation and metabolism of leukotrienes in the ionophore-stimulated blood of normal and asthmatic subjects.Pulm Pharmacol. 1990;3(3):111-9. doi: 10.1016/0952-0600(90)90041-g. Pulm Pharmacol. 1990. PMID: 1966905
-
Reduction in leukotriene B4 generation by bronchoalveolar lavage cells in asthma.Thorax. 1995 Jan;50(1):67-73. doi: 10.1136/thx.50.1.67. Thorax. 1995. PMID: 7886653 Free PMC article.
-
[Release of leukotrienes (LTC4, D4, E4, B4) from peripheral leukocytes in patients with bronchial asthma].Arerugi. 1990 Dec;39(12):1556-66. Arerugi. 1990. PMID: 2096801 Japanese.
-
A role for leukotriene antagonists in atopic dermatitis?Am J Clin Dermatol. 2001;2(1):1-6. doi: 10.2165/00128071-200102010-00001. Am J Clin Dermatol. 2001. PMID: 11702615 Review.
-
The role of leukotrienes in allergic diseases.Allergol Int. 2015 Jan;64(1):17-26. doi: 10.1016/j.alit.2014.09.001. Epub 2014 Nov 22. Allergol Int. 2015. PMID: 25572555 Review.
Cited by
-
Persistent increase in plasma and urinary leukotrienes after acute asthma.Arch Dis Child. 1995 Sep;73(3):221-5. doi: 10.1136/adc.73.3.221. Arch Dis Child. 1995. PMID: 7492159 Free PMC article.
-
Leukotriene A4 hydrolase in peripheral leukocytes of patients with atopic dermatitis.Arch Dermatol Res. 1996 Apr;288(4):168-72. doi: 10.1007/BF02505219. Arch Dermatol Res. 1996. PMID: 8967787
-
Eicosanoid mediator expression in mononuclear and polymorphonuclear cells in normal subjects and patients with atopic asthma and cystic fibrosis.Thorax. 1996 Dec;51(12):1223-8. doi: 10.1136/thx.51.12.1223. Thorax. 1996. PMID: 8994519 Free PMC article.
-
Leukotrienes as a target in asthma therapy.Drugs. 1994 Jan;47(1):12-24. doi: 10.2165/00003495-199447010-00002. Drugs. 1994. PMID: 7510618 Review.
-
Priming effect of platelet activating factor on leukotriene C4 from stimulated eosinophils of asthmatic patients.Thorax. 1996 Feb;51(2):155-8. doi: 10.1136/thx.51.2.155. Thorax. 1996. PMID: 8711647 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous